BIKEN Foundation
↗Suita, Japan
The BIKEN Foundation is a leading Japanese nonprofit organization dedicated to the research, development, and manufacture of vaccines. Established in 1934, it has pioneered numerous vaccines in Japan, including the world-renowned Oka varicella strain. The organization operates through the BIKEN Group, which includes a manufacturing joint venture with Mitsubishi Tanabe Pharma.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$500M-$1B (Estimated based on asset size)
Founded:1934
Ownership:nonprofit
Status:operating
FUNDING
Investors:Government of Japan (AMED), MHLW
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Live attenuated vaccine, Inactivated vaccine, Replicon RNA
Active Trials:5
Trial Phases:Phase 1: 2 | Phase 2: 2 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:BIKEN Co., Ltd., BIKEN-Sanofi
Key Partnerships:Mitsubishi Tanabe Pharma, VLP Therapeutics Japan, Sanofi, WHO
COMPETITION
Position:Leader
Competitors:Takeda, Daiichi Sankyo, KM Biologics, Pfizer, Moderna
LEADERSHIP
Key Executives:
Yoshihiro Yoneda - Director General
Scientific Founders:Dr. Taniguchi
Board Members:Naobumi Sato, Seiichi Murakami
LINKS
Website:mail.biken.or.jp
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BIKEN Foundation. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.